Biased by design? Clinical trials and patient benefit in oncology
Author:
Affiliation:
1. The Anticancer Fund, 1853 Strombeek-Bever, Brussels, Belgium
2. The George Pantziarka TP53 Trust, London, UK
3. Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical & Pharmacological Sciences, KU Leuven, Belgium
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon-2019-0763
Reference35 articles.
1. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
2. Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012
3. An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate
4. Toward Progression-Free Survival As a Primary End Point in Advanced Colorectal Cancer
5. Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Issues and challenges to reproducibility of cancer research: a commentary;Future Oncology;2022-04
2. Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment;The Lancet Oncology;2021-10
3. Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma;Expert Review of Hematology;2021-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3